anmelden
OMX Nordic 40
2.612,41
PKT
-23,79
PKT
-0,90
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu OMX Nordic 40-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 02.12.22 | Nokia Buy | Goldman Sachs Group Inc. | |
| 02.12.22 | Hennes Mauritz (H M, H&M) Neutral | Goldman Sachs Group Inc. | |
| 02.12.22 | Nokia Overweight | JP Morgan Chase & Co. | |
| 01.12.22 | Hennes Mauritz (H M, H&M) Overweight | Barclays Capital | |
| 28.11.22 | Hennes Mauritz (H M, H&M) Sell | Goldman Sachs Group Inc. | |
| 25.11.22 | Hennes Mauritz (H M, H&M) Hold | Jefferies & Company Inc. | |
| 25.11.22 | Novo Nordisk Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 22.11.22 | Nokia Buy | UBS AG | |
| 22.11.22 | Hennes Mauritz (H M, H&M) Sector Perform | RBC Capital Markets | |
| 21.11.22 | ABB (Asea Brown Boveri) Outperform | RBC Capital Markets | |
| 21.11.22 | Hennes Mauritz (H M, H&M) Sell | Goldman Sachs Group Inc. | |
| 18.11.22 | Hennes Mauritz (H M, H&M) Underweight | JP Morgan Chase & Co. | |
| 14.11.22 | AstraZeneca Overweight | Barclays Capital | |
| 14.11.22 | Novo Nordisk Overweight | Barclays Capital | |
| 11.11.22 | AstraZeneca Buy | Deutsche Bank AG | |
| 10.11.22 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 10.11.22 | AstraZeneca Neutral | UBS AG | |
| 10.11.22 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 10.11.22 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 09.11.22 | ABB (Asea Brown Boveri) Hold | Jefferies & Company Inc. | |
| 09.11.22 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 09.11.22 | Nokia Buy | Deutsche Bank AG | |
| 08.11.22 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 08.11.22 | Volvo (B) Buy | Goldman Sachs Group Inc. | |
| 07.11.22 | Hennes Mauritz (H M, H&M) Sector Perform | RBC Capital Markets | |
| 04.11.22 | Novo Nordisk Buy | Deutsche Bank AG | |
| 03.11.22 | Novo Nordisk Neutral | Credit Suisse Group | |
| 03.11.22 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 03.11.22 | Novo Nordisk Buy | Deutsche Bank AG | |
| 02.11.22 | A.P. Moeller - Maersk A-S (B) Buy | UBS AG | |
| 02.11.22 | Novo Nordisk Sell | UBS AG | |
| 02.11.22 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 02.11.22 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 01.11.22 | AstraZeneca Overweight | Barclays Capital | |
| 31.10.22 | ABB (Asea Brown Boveri) Buy | Goldman Sachs Group Inc. | |
| 27.10.22 | AstraZeneca Overweight | Barclays Capital | |
| 26.10.22 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 25.10.22 | Volvo (B) Sell | UBS AG | |
| 24.10.22 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 24.10.22 | ABB (Asea Brown Boveri) Buy | UBS AG |